| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.006 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |